Biocidal active substances and biocidal products are defined as products that exert a controlling effect on harmful organisms. This definition is broad in scope, and includes the extermination, rendering harmless, or prevention of harmful organisms. The BPR takes a two-pronged approach with regard to biocides: first, biocidal active ingredients must undergo an approval process; and second, biocidal products including approved active substances are submitted to an authorisation process. The approval process consists of a peer review/risk assessment that, when completed and approved, signals that the European Commission has confirmed the substance in question is sufficiently safe and effective and can be used on the EU market. Additionally, the authorisation process requires the biocidal product to be authorised by either the EU or a Member State Competent Authority in which it will be used.
The aim of the BPR (Biocidal Product Regulation) is to provide an unrivalled degree of protection for humans and the environment. Considering this, the appropriate development, technological advancement and sustainable use of microbial control technologies have been at the heart of the MCEC members’ commitment to health and safety, as well as the betterment of society. It is therefore the goal of MCEC members to ensure that all necessary precautions are followed to guarantee the risk to humans and the environment is minimal. Safety and performance are at the core of the microbial control industry. Microbial control technologies are therefore the subject of extensive research, testing and registration. As these products are intended to control a wide variety of harmful or unwanted organisms, it is important that safeguards are followed to ensure they are used without causing harm to people, the environment or wildlife.